Anastrozole is a highly selective nonsteroidal aromatase inhibitor. It is approved for the treatment of hormone receptor‑positive breast cancer in postmenopausal women. Nonetheless, aromatase inhibitors have also been used off‑label for many years in men. This article outlines empirical non‑oncological anastrozole uses in men and briefly presents some current clinical trials involving the male population.